- Reports /
- Blood Collection Tubes Market
Blood Collection Tubes Market
Blood Collection Tubes Market Market Research Report – Segmented By Product Type (Serum Separating Tubes, EDTA Tubes, Plasma Separation Tubes, Rapid Serum Tubes, Others) & Region (North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2019 to 2027.
Table of contents
- Executive Summary
- Market Overview
- Industry Analysis
- Market Analysis
- By Product Type
- North America
- Europe
- Asia-Pacific
- Middle-East & Africa
- Latin America
- Company Analysis
- Competitive Analysis
- Research Methodology
- Appendix
Executive Summary
Blood Collection Tubes Market was valued at US $1,975.29 million in 2021 and is projected to grow at 8.46% CAGR over the forecast period to reach US $3,215.39 million by 2027. Blood Collection Tubes Market represented US $296.11 million opportunity over 2019-2021 and estimated to create US $1,240.11 million opportunity in 2027 over 2021.
Blood Collection Tubes from Consainsights analyses the Blood Collection Tubes Market in the Life Sciences industry over the forecast period to 2027.
Blood Collection Tubes research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.
Blood Collection Tubes segmentation includes Product Type and Geography.
Based on the Product Type, the Blood Collection Tubes analysis covers Serum Separating Tubes, EDTA Tubes, Plasma Separation Tubes, Rapid Serum Tubes, Others.
In Product Type segment, Serum Separating Tubes segment has highest cagr growth of 7.49%.
Based on the region, the Blood Collection Tubes analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.
Key companies operating in the market include Becton, Dickinson and Company, Greiner Bio One International GmbH, QIAGEN, FL MEDICAL s.r.l., AdvaCare Pharmaceuticals, Narang Medical Limited, Sarstedt AG & Co, Hindustan Syringes & Medical Devices Ltd and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.
Market Overview
Definition & Scope
The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.
The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.
The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.
Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.
Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.
As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.
Currency, Year & Forecast
The currency used in this report is USD, with the market size indicated in terms of USD million/billion.
For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.
For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.
Product Type
Introduction
In 2021, Serum Separating Tubes segment has the highest revenue of US $871.00 million and is expected to grow at CAGR of 7.49% by 2027 Serum Separating Tubes segment has highest cagr growth of 7.49%.
Serum Separating Tubes
Serum Separating Tubes segment was valued at US $740.43 million in 2019 and is projected to grow at 7.49% CAGR over the forecast period to reach US $1,417.82 million by 2027. Serum Separating Tubes segment represented US $130.57 million opportunity over 2019-2021 and estimated to create US $546.82 million opportunity in 2027 over 2021.
EDTA Tubes
EDTA Tubes segment was valued at US $372.47 million in 2019 and is projected to grow at 7.49% CAGR over the forecast period to reach US $713.24 million by 2027. EDTA Tubes segment represented US $65.68 million opportunity over 2019-2021 and estimated to create US $275.08 million opportunity in 2027 over 2021.
Plasma Separation Tubes
Plasma Separation Tubes segment was valued at US $198.16 million in 2019 and is projected to grow at 7.49% CAGR over the forecast period to reach US $379.44 million by 2027. Plasma Separation Tubes segment represented US $34.94 million opportunity over 2019-2021 and estimated to create US $146.34 million opportunity in 2027 over 2021.
Rapid Serum Tubes
Rapid Serum Tubes segment was valued at US $224.25 million in 2019 and is projected to grow at 7.49% CAGR over the forecast period to reach US $429.41 million by 2027. Rapid Serum Tubes segment represented US $39.55 million opportunity over 2019-2021 and estimated to create US $165.61 million opportunity in 2027 over 2021.
Others
Others segment was valued at US $143.87 million in 2019 and is projected to grow at 7.49% CAGR over the forecast period to reach US $275.48 million by 2027. Others segment represented US $25.37 million opportunity over 2019-2021 and estimated to create US $106.25 million opportunity in 2027 over 2021.